MammaTyper

MammaTyper

Innovation in breast cancer diagnosis

Molecular in vitro diagnostic test for the quantitative detection of the mRNA expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue

  • Overview

    Breast Cancer
    Breast cancer is the most common cancer worldwide including India, with one in eight women diagnosed with the disease during their lifetime and more than 464,000 new cases diagnosed in 2012 alone. (29% of female cases and 13% of the total cancer cases).

    Breast cancer projection for India during time periods 2020 suggests the number to go as high as 17,97,900. (Indication by NCBI)
    Read More
  • About MammaTyper

    Innovation in breast cancer diagnosis
    Molecular in vitro diagnostic test for the quantitative detection of the mRNA expression of ERBB2, ESR1, PGR and MKI67 in breast cancer tissue
    Read More
  • Diagnosis

    To identify potential cancers as early as possible specific screening procedures are available and promoted through screening programs such as:
    • Breast Physical Examination
    • Breast Self-Examination
    • CT Scans (Computerized Tomography)
    • Chest X-Rays
    • Ultrasound
    Read More
  • Molecular Subtypes

    The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel recommends the use of four biomarkers for molecular subtyping of breast cancer:

    • ERBB2 (HER2, human epidermal growth factor receptor 2)
    • ESR1 (estrogen receptor 1)
    • PGR (progesterone receptor)
    • MKI67 (marker of proliferation Ki-67, a marker expressed in proliferating cells)
    Read More
  • Biomarker

    ERBB2 is the name of the gene for human epidermal growth factor receptor 2 (HER2). This receptor is a cell surface protein which belongs to the family of epidermal growth factor receptors. ERBB2 activation stimulates cell proliferation and inhibits programmed cell death. ERBB2 has an important role in breast cancer. About 20 % of all breast cancers show an overexpression of this receptor, which is associated with poor prognosis and clinical outcome.
    Read More
  • Therapy

    In recent years numerous life-saving treatment options have been developed for the therapy of breast cancer. Today there is a wide selection of treatments available to fight each individual breast cancer type. For a personalized treatment recommendation different approaches are selected and combined based on a sound diagnosis.
    Clinical parameters guide the oncologist in assessing the suitable intervention
    Read More
  • FAQs for Patients

    My Mammography result showed abnormalities. What is the next step?

    You may require to undertake take a biopsy sample of your breast tissue as guided by your clinician.
    Read More
  • FAQs for Oncologists

    Here Is A Guide For You To Know In Details About The Services Offered By Our Laboratory.

    The FAQ section is a ready reckoner for any and all queries that you may have. In case, you still have further questions, feel free to write in to us!
    Read More